Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Standard Biotools (LAB) Gross Profit (2016 - 2025)

Standard Biotools (LAB) has disclosed Gross Profit for 16 consecutive years, with $792000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Gross Profit fell 93.47% to $792000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $64.2 million, a 0.59% decrease, with the full-year FY2024 number at $84.3 million, up 67.02% from a year prior.
  • Gross Profit was $792000.0 for Q3 2025 at Standard Biotools, down from $10.6 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $47.4 million in Q3 2021 to a low of -$9.6 million in Q4 2021.
  • A 5-year average of $15.5 million and a median of $13.4 million in 2023 define the central range for Gross Profit.
  • Biggest YoY gain for Gross Profit was 569.48% in 2021; the steepest drop was 122.9% in 2021.
  • Standard Biotools' Gross Profit stood at -$9.6 million in 2021, then skyrocketed by 216.5% to $11.2 million in 2022, then grew by 19.61% to $13.4 million in 2023, then surged by 147.36% to $33.0 million in 2024, then crashed by 97.6% to $792000.0 in 2025.
  • Per Business Quant, the three most recent readings for LAB's Gross Profit are $792000.0 (Q3 2025), $10.6 million (Q2 2025), and $19.7 million (Q1 2025).